Resource Logo
FDA News

July 25 webinar on Draft Guidance: Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment




 

On July 25, 2013, at 1:30PM (ET), FDA will present a webinar on a new draft guidance entitled "Draft Guidance for Industry on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment"

This webinar,intended to encourage the submission of questions or comments while the guidance is still in draft form, will provide an opportunity to learn about the guidance from individuals involved in its preparation.

Questions may be submitted online during the webinar and will be addressed as time permits. All comments should also be submitted to docket  so that they can be formally processed by FDA.

DRAFT Guidance

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM355128.pdf

Federal Register Notice

http://www.gpo.gov/fdsys/pkg/FR-2013-06-05/pdf/2013-13288.pdf 

The Comment Period Will Close on 08/09/2013.

Please plan to join.  Your comments are important.

Richard Klein
Office of Health and Constituent Affairs
Food and Drug Administration

Kimberly Struble
Division of Antiviral Products
Food and Drug Administration

Steve Morin
Office of Health and Constituent Affairs
Food and Drug Administration



 


Copyright © 2013 -FDA News, Publisher. All rights reserved to Food and Drug (FDA) Administration FDA.

Information in this article was accurate in July 19, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.